Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer’s drug
Leqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
Source link
Leqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
Source link